• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体液免疫应答对 2 型猪繁殖与呼吸综合征病毒的不同免疫途径的差异。

Differences in Humoral Immune Response against the Type 2 Porcine Reproductive and Respiratory Syndrome Virus via Different Immune Pathways.

机构信息

College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.

College of Life Science, Henan Agricultural University, Jinshui District, Zhengzhou 450002, China.

出版信息

Viruses. 2022 Jun 29;14(7):1435. doi: 10.3390/v14071435.

DOI:10.3390/v14071435
PMID:35891415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9316826/
Abstract

The intramuscular vaccine is the principal strategy to protect pigs from porcine reproductive and respiratory syndrome virus (PRRSV), However, it is still difficult to control PRRSV effectively. This study infected piglets with PRRSV through intramuscular and intranasal inoculation. Subsequently, viral loads, anti-PRRSV antibody levels, and neutralizing antibodies (NAs) titers in both serum and saliva were monitored for 43 days. Meanwhile, tissues were obtained through necropsy at 43 days post-inoculation (dpi) to detect viral loads. The results indicated that viremia lasted from 3 to 31 dpi in both the inoculation groups, but the viruses survived in the lungs and lymph nodes after viremia clearance. The antibody response was detected from 11 dpi, but the response of NAs was delayed until 3-4 weeks. Furthermore, intranasal inoculation induced lower viral load levels than injection inoculation. In addition, positive SIgA and NAs levels were produced early, with higher levels through intranasal inoculation. Therefore, our data indicated that a more robust antibody response and lower virus loads could be induced by intranasal inoculation, and mucosal inoculation could be a suitable pathway for PRRSV vaccines.

摘要

肌肉内疫苗是保护猪免受猪繁殖与呼吸综合征病毒(PRRSV)感染的主要策略。然而,目前仍难以有效控制 PRRSV。本研究通过肌肉内和鼻腔接种感染仔猪,然后监测 43 天内血清和唾液中的病毒载量、抗 PRRSV 抗体水平和中和抗体(NA)滴度。同时,在接种后 43 天通过剖检获得组织以检测病毒载量。结果表明,两种接种组的病毒血症持续时间为 3 至 31 天,但病毒在清除病毒血症后仍存在于肺部和淋巴结中。抗体反应从 11 天开始检测,但 NA 反应延迟至 3-4 周。此外,鼻腔接种引起的病毒载量水平低于注射接种。此外,鼻腔接种可更早地产生阳性 SIgA 和 NA 水平,且水平更高。因此,我们的数据表明,鼻腔接种可诱导更强烈的抗体反应和更低的病毒载量,黏膜接种可能是 PRRSV 疫苗的合适途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/4edcb39fe507/viruses-14-01435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/21660d8b9797/viruses-14-01435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/3c1d6c134320/viruses-14-01435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/469b38923170/viruses-14-01435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/9fe3cb7396f7/viruses-14-01435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/479f94d5fbb1/viruses-14-01435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/4edcb39fe507/viruses-14-01435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/21660d8b9797/viruses-14-01435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/3c1d6c134320/viruses-14-01435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/469b38923170/viruses-14-01435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/9fe3cb7396f7/viruses-14-01435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/479f94d5fbb1/viruses-14-01435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d92/9316826/4edcb39fe507/viruses-14-01435-g006.jpg

相似文献

1
Differences in Humoral Immune Response against the Type 2 Porcine Reproductive and Respiratory Syndrome Virus via Different Immune Pathways.体液免疫应答对 2 型猪繁殖与呼吸综合征病毒的不同免疫途径的差异。
Viruses. 2022 Jun 29;14(7):1435. doi: 10.3390/v14071435.
2
The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus.针对 2 型猪繁殖与呼吸综合征病毒同源和异源株的局部和系统体液免疫应答。
Front Immunol. 2021 Mar 9;12:637613. doi: 10.3389/fimmu.2021.637613. eCollection 2021.
3
Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.用实验场特异性和商业 PRRSV 疫苗对 PRRSV 免疫母猪进行加强免疫后的抗体反应和母源免疫力。
Vet Microbiol. 2013 Dec 27;167(3-4):260-71. doi: 10.1016/j.vetmic.2013.08.017. Epub 2013 Aug 28.
4
Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.在猪圆环病毒2型(PCV2)-猪繁殖与呼吸综合征病毒(PRRSV)攻毒模型中,猪圆环病毒2型(PCV2)疫苗和猪繁殖与呼吸综合征病毒(PRRSV)疫苗的比较效果
Clin Vaccine Immunol. 2013 Mar;20(3):369-76. doi: 10.1128/CVI.00497-12. Epub 2013 Jan 9.
5
Potentiation of Taishan Pinus massoniana pollen polysaccharide on the immune response and protection elicited by a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit in pigs.泰山马尾松花粉多糖对高致病性猪繁殖与呼吸综合征病毒糖蛋白5亚基在猪体内引发的免疫反应及保护作用的增强
Mol Cell Probes. 2016 Apr;30(2):83-92. doi: 10.1016/j.mcp.2016.01.008. Epub 2016 Jan 30.
6
A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.一种基于合成减毒病毒工程方法的猪繁殖与呼吸综合征病毒候选疫苗具有减毒作用,且能有效抵御同源病毒攻击。
Vaccine. 2016 Nov 4;34(46):5546-5553. doi: 10.1016/j.vaccine.2016.09.049. Epub 2016 Oct 11.
7
Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.用猪繁殖与呼吸综合征病毒样颗粒加2',3'-环鸟苷酸VacciGrade™佐剂对猪进行鼻内免疫会在病毒攻击后加重病毒血症。
Virol J. 2017 Apr 12;14(1):76. doi: 10.1186/s12985-017-0746-0.
8
Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection.猪繁殖与呼吸综合征病毒感染中同源和异源适应性免疫应答的特征。
Vet Res. 2012 Apr 19;43(1):30. doi: 10.1186/1297-9716-43-30.
9
Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.共表达欧洲型猪繁殖与呼吸综合征病毒GP3和GP5的DNA疫苗增强猪的免疫反应
J Virol Methods. 2014 Sep;206:27-37. doi: 10.1016/j.jviromet.2014.05.021. Epub 2014 May 29.
10
Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection.急性和慢性感染期间针对猪繁殖与呼吸综合征病毒的免疫反应。
Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):283-92. doi: 10.1016/j.vetimm.2008.08.002. Epub 2008 Aug 20.

引用本文的文献

1
Current Status of Vaccines for Porcine Reproductive and Respiratory Syndrome: Interferon Response, Immunological Overview, and Future Prospects.猪繁殖与呼吸综合征疫苗的现状:干扰素反应、免疫学概述及未来展望
Vaccines (Basel). 2024 Jun 1;12(6):606. doi: 10.3390/vaccines12060606.
2
Mass Spectrometry-Based Proteomic Analysis of Potential Host Proteins Interacting with GP5 in PRRSV-Infected PAMs.基于质谱分析的猪繁殖与呼吸综合征病毒感染的肺泡巨噬细胞中与GP5相互作用的潜在宿主蛋白的蛋白质组学分析
Int J Mol Sci. 2024 Feb 28;25(5):2778. doi: 10.3390/ijms25052778.
3
The Molecular and Function Characterization of Porcine MID2.

本文引用的文献

1
The Ability of Porcine Reproductive and Respiratory Syndrome Virus Isolates to Induce Broadly Reactive Neutralizing Antibodies Correlates With Protection.猪繁殖与呼吸综合征病毒分离株诱导广泛反应性中和抗体的能力与保护作用相关。
Front Immunol. 2021 Jul 26;12:691145. doi: 10.3389/fimmu.2021.691145. eCollection 2021.
2
Advances in Development and Application of Influenza Vaccines.流感疫苗的研发与应用进展。
Front Immunol. 2021 Jul 13;12:711997. doi: 10.3389/fimmu.2021.711997. eCollection 2021.
3
Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2021).
猪MID2的分子与功能特性
Animals (Basel). 2023 Sep 8;13(18):2853. doi: 10.3390/ani13182853.
4
The Host E3-Ubiquitin Ligase TRIM28 Impedes Viral Protein GP4 Ubiquitination and Promotes PRRSV Replication.宿主 E3-泛素连接酶 TRIM28 抑制病毒蛋白 GP4 的泛素化并促进 PRRSV 复制。
Int J Mol Sci. 2023 Jun 30;24(13):10965. doi: 10.3390/ijms241310965.
5
Immune Molecules' mRNA Expression in Porcine Alveolar Macrophages Co-Infected with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus Type 2.猪肺泡巨噬细胞中免疫分子的 mRNA 表达与猪繁殖与呼吸综合征病毒和猪圆环病毒 2 共感染。
Viruses. 2023 Mar 17;15(3):777. doi: 10.3390/v15030777.
6
An ambient-temperature stable nanoparticle-based vaccine for nasal application that confers long-lasting immunogenicity to carried antigens.一种基于纳米颗粒的室温稳定疫苗,可用于鼻腔应用,为携带的抗原提供持久的免疫原性。
Front Immunol. 2022 Oct 31;13:1057499. doi: 10.3389/fimmu.2022.1057499. eCollection 2022.
病毒分类学和国际病毒分类与命名法规的变更获国际病毒学分类委员会批准(2021 年)。
Arch Virol. 2021 Sep;166(9):2633-2648. doi: 10.1007/s00705-021-05156-1.
4
Damage to intestinal barrier integrity in piglets caused by porcine reproductive and respiratory syndrome virus infection.猪繁殖与呼吸综合征病毒感染导致仔猪肠屏障完整性受损。
Vet Res. 2021 Jun 23;52(1):93. doi: 10.1186/s13567-021-00965-3.
5
Evaluation of oral fluid as an aggregate sample for early detection of African swine fever virus using four independent pen-based experimental studies.采用四项独立的基于笔的实验研究评估口腔液作为用于早期检测非洲猪瘟病毒的聚合样本。
Transbound Emerg Dis. 2021 Sep;68(5):2867-2877. doi: 10.1111/tbed.14175. Epub 2021 Jun 17.
6
Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?鼻内接种 SARS-CoV-2 疫苗:与肌肉内疫苗协同还是替代?
Int J Pharm. 2021 Jun 15;603:120686. doi: 10.1016/j.ijpharm.2021.120686. Epub 2021 May 6.
7
Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A "Leaky" Vaccine with Debatable Efficacy and Safety.猪繁殖与呼吸综合征弱毒活疫苗:一种效力和安全性存疑的“渗漏”疫苗。
Vaccines (Basel). 2021 Apr 9;9(4):362. doi: 10.3390/vaccines9040362.
8
The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus.针对 2 型猪繁殖与呼吸综合征病毒同源和异源株的局部和系统体液免疫应答。
Front Immunol. 2021 Mar 9;12:637613. doi: 10.3389/fimmu.2021.637613. eCollection 2021.
9
Commercial PRRS Modified-Live Virus Vaccines.商业性猪繁殖与呼吸综合征弱毒活疫苗
Vaccines (Basel). 2021 Feb 22;9(2):185. doi: 10.3390/vaccines9020185.
10
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.鼻腔内接种慢病毒载体可预防临床前动物模型中的 SARS-CoV-2。
Cell Host Microbe. 2021 Feb 10;29(2):236-249.e6. doi: 10.1016/j.chom.2020.12.010. Epub 2020 Dec 16.